All these results, even conflicting, suggest that a CD274 positive expression could be a negative prognostic factor in CRC, potentially helping clinicians to stratify patients for immunotherapy, especially MSI-H/dMMR patients [101,102]. This evidence concerns the gene CD274 and colorectal carcinoma.